Country/Region

March 18, 2010

NY Times Lettter-to-the-Editor on MSF concerns that a provision in proposed U.S. health care legislation will allow pharmaceutical companies to extend monopolies on high-priced, cutting-edge medicines.

March 03, 2010

MSF testified at a hearing before the US Trade Representative about the effect of US trade and intellectual property pressures on global health policy and efforts to expand access to affordable medicines in developing countries.

January 11, 2010

Doctors Without Borders is urging law makers to revise a provision in the U.S. health care legislation that would essentially allow pharmaceutical companies to extend their monopolies on a rapidly expanding and high-priced brand of drugs known as biologics. Biologics--medicines derived from living cells--hold great promise for new vaccines and medicines. Unfortunately, the biologics provision in the current legislation will create a massive barrier to developing generic versions of these cutting-edge drugs.

December 08, 2009

A Speech by Dr. Christophe Fournier, MSF's International Council President, given at a NATO gathering in Germany

March 31, 2009

Falling through the Cracks: The Mounting Health Crisis amid Situations of Precarious Stability

Statement by Sophie Delaunay, Executive Director Médecins Sans Frontières

On behalf of Médecins Sans Frontières (MSF), I would like to thank the President of the Economic and Social Council for the opportunity to speak on the important topic of “health challenges in post-crisis situations.”

February 23, 2009

Statement by Sophie Delaunay Executive Director, MSF-USA

This annual Ministerial review focusing on philanthropy and the Global Health Agenda clearly shows recognition of the urgency to address global health challenges. However, this initiative cannot replace the critical need for greater government leadership to stimulate medical innovation for neglected diseases affecting millions in the poorest corners of the world.

July 29, 2008


MSF official statement

Once again in this type of situation, there is a lot of confusion introduced, whether deliberately or through a lack of correct information, between the role of the states that have ratified the statute of the International Criminal Court (ICC), the United Nations, and the activities of independent humanitarian organizations such as Doctors Without Borders/Médecins Sans Frontières (MSF).

May 22, 2008

Before the High Level task force communicates its first Comprehensive Framework for Action, Médecins Sans Frontières urges careful consideration of the population that is most vulnerable to the dire consequences of malnutrition – children under two.

April 30, 2008

My name is Dr. Tido von Schoen-Angerer and I am speaking on behalf of Médecins Sans Frontières. Thank you for the opportunity to address this important gathering.

In 2000, I was working in one of MSF’s AIDS projects. Our response to the pandemic was one based on a simple medical decision: faced with the urgency of patients dying, the only acceptable response was to treat. This was an ethical imperative, to treat, regardless of the difficulties.

March 15, 2007

U.S congressional briefing delivered by Dr. Buddhima Lokuge, U.S. Manager of MSF's Campaign for Access to Essential Medicines on Thailand's compulsory drug licensing.

Pages